natgillin/translations-raw huggingface dataset:
The most commonly reported adverse reactions are diarrhoea and headache, both occurring in approximately 1% of patients. 
Najčešće prijavljene nuspojave su proljev i glavobolja, koje se javljaju u otprilike 1% bolesnika.
Very common (≥ 1/10); common (≥ 1/100 to < 1/10); uncommon (≥ 1/1,000 to < 1/100); rare (≥ 1/10,000 to < 1/1,000); very rare (< 1/10,000), not known (cannot be estimated from the available data). 
Vrlo često (≥ 1/10), često (≥ 1/100 i < 1/10), manje često (≥ 1/1000 i < 1/100), rijetko (≥ 1/10 000 i < 1/1000), vrlo rijetko (< 1/10 000), nepoznato (ne može se procijeniti iz dostupnih podataka).
If possible take your medicine and this leaflet with you 
Ako je moguće ponesite lijek i ovu Uputu sa sobom.
Hallucination; Confusion (especially in pre-disposed patients, as well as the aggravation of these symptoms in case of pre-existence) 
halucinacije; konfuzija (posebno u predisponiran ih bolesnika, kao i pogoršanje tih simptoma ako su već bili prisutni)
Always take this medicine exactly as described in this leaflet or as your doctor or pharmacist have told you. 
Uvijek uzmite ovaj lijek točno onako kako je opisano u ovoj uputi ili kako Vam je rekao liječnik ili ljekarnik.
If you take CONTROLOC Control for longer periods, this may cause additional risks, such as: 
Uzimanje lijeka Controloc Control tijekom duljih razdoblja može izazvati dodatne rizike, kao što su:
CONTROLOC Control 20 mg gastro-resistant tablets should not be chewed or crushed, and should be swallowed whole with liquid before a meal. 
CONTROLOC Control 20 mg želučanootporne tablete se ne smiju žvakati ni lomiti, već ih se mora progutati cijele s tekućinom prije obroka.
What you need to know before you take CONTROLOC Control 
Što morate znati prije nego počnete uzimati CONTROLOC Control
What CONTROLOC Control is and what it is used for What you need to know before you take CONTROLOC Control How to take CONTROLOC Control Possible side effects 
Što je CONTROLOC Control i za što se koristi Što morate znati prije nego počnete uzimati CONTROLOC Control Kako uzimati CONTROLOC Control Moguće nuspojave
CONTROLOC Control is available in Alu/Alu blisters with or without cardboard reinforcement. 
Control je dostupan u Al/Al blisterima sa ili bez kartonskog pojačanja.
How to store CONTROLOC Control Contents of the pack and other information 
Kako čuvati CONTROLOC Control Sadržaj pakiranja i druge informacije
{ mm/yyyy} 
{MM/GGGG}
CONTROLOC Control should not be used by children and adolescents under 18 years of age due to a lack of safety information in this younger age group. 
Control ne smiju koristiti djeca i mladi u dobi do 18 godina jer ne postoje podaci o sigurnosti primjene u ovoj mlađoj dobnoj skupini.
What CONTROLOC Control contains - The active substance is pantoprazole. 
Što CONTROLOC Control sadrži - Djelatna tvar je pantoprazol.
However adverse reactions such as dizziness and visual disturbances may occur (see section 4.8). 
Međutim, mogu se pojaviti nuspojave poput omaglice i poremećaja vida (vidjeti dio 4.8).
Observational studies suggest that proton pump inhibitors may increase the overall risk of fracture by 10-40%. 
Opservacijska ispitivanja ukazuju da inhibitori protonske pumpe mogu povećati ukupni rizik od prijeloma za 10-40%.
Stevens-Johnson syndrome; Lyell syndrome; 
StevensJohnsonov sindrom;
CONTROLOC Control has no or negligible influence on the ability to drive and use machines. 
Control ne utječe ili neznatno utječe na sposobnost upravljanja vozilima ili rada sa strojevima.
- You must talk to a doctor if you do not feel better or if you feel worse after 2 weeks. 
Pogledajte dio 4. - Obavezno se obratite liječniku ako se ne osjećate bolje ili ako se osjećate lošije nakon 2 tjedna.
Disorientation (and all aggravations) 
dezorijentiranost (i pogoršanje istog)
Detailed information on this medicine is available on the European Medicines Agency web site: http:// www.ema.europa.eu/. 
Detaljnije informacije o ovom lijeku dostupne su na web stranici Europske agencije za lijekove: http://www.ema.europa.eu/.
If you take more CONTROLOC Control than you should Tell your doctor or pharmacist if you have taken more than the recommended dose. 
Control nego što ste trebali Obavijestite liječnika ili ljekarnika ako ste uzeli više od preporučene doze.
Other medicines and CONTROLOC Control 
Drugi lijekovi i CONTROLOC Control
Penetration of the placenta was investigated in the rat and was found to increase with advanced gestation. 
Prodiranje kroz placentu je ispitano na štakorima i otkriveno je da se povećava s napredovanjem gestacije.
Alu/Alu blisters with or without cardboard reinforcement containing 7 or 14 gastro-resistant tablets 
Al/Al blisteri sa ili bez kartonskog pojačanja koji sadrže 7 ili 14 želučanootpornih tableta.
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder: 
Za sve dodatne informacije ovom lijeku obratite se lokalnom predstavniku nositelja odobrenja za stavljanje gotovog lijeka u promet.
If lesions occur, especially in sun-exposed areas of the skin, and if accompanied by arthralgia, the patient should seek medical help promptly and the health care professional should consider stopping CONTROLOC Control. 
Ako nastupe lezije, posebice na suncem izloženim područjima kože, te ako su popraćene artralgijom, bolesnik treba odmah potražiti medicinsku pomoć, a zdravstveni radnik treba razmotriti prekid liječenja lijekom CONTROLOC Control.
CONTROLOC Control should not be used during breast-feeding. 
Controloc Control ne smije se koristiti tijekom dojenja.
CONTROLOC Control contains the active substance pantoprazole, which blocks the ‘pump' that produces stomach acid. 
Control sadrži djelatnu tvar pantoprazol, koja blokira „pumpu“ koja proizvodi želučanu kiselinu.
To avoid this interference, CONTROLOC Control treatment should be stopped for at least 5 days before CgA measurements (see section 5.1). 
Control potrebno je prekinuti najmanje 5 dana prije mjerenja razine CgA (vidjeti dio 5.1.).
- falling magnesium levels in your blood (potential symptoms: fatigue, involuntary muscle contractions, disorientation, convulsions, dizziness, increased heart rate). 
- smanjenje razine magnezija u krvi (potencijalni simptomi: umor, nevoljno stezanje mišića, dezorijentacija, konvulzije, omaglica, povećan broj otkucaja srca).
Other side effects include: - Common (may affect up to 1 in 10 people): Benign polyps in the stomach. 
Ostale nuspojave uključuju: - Česte nuspojave (mogu se javiti u do 1 na 10 osoba): dobroćudni polipi u želucu.
Within the following table, adverse reactions are ranked under the MedDRA frequency classification: 
Unutar sljedeće tablice nuspojave su razvrstane prema MedDRA klasifikaciji učestalosti:
Do not take CONTROLOC Control with other medicines which limit the amount of acid produced in your stomach, such as another proton pump inhibitor (omeprazole, lansoprazole or rabeprazole) or an H2 antagonist (e.g. ranitidine, famotidine). 
Ne uzimajte CONTROLOC Control s drugim lijekovima koji ograničavaju količinu proizvodnje želučane kiseline, kao što su drugi inhibitor protonske pumpe (omeprazol, lanzoprazol ili rabeprazol) ili H2 antagonist (npr. ranitidin, famotidin).
Do not take a double dose to make up for the forgotten dose. 
Ako ste zaboravili uzeti CONTROLOC Control Nemojte uzeti dvostruku dozu kako biste nadoknadili zaboravljenu dozu.
Do not take CONTROLOC Control: - if you are allergic to pantoprazole or to any of the other ingredients of this medicine (listed in section 6) - if you are taking HIV protease inhibitors such as atazanavir; nelfinavir (for the treatment of 
Nemojte uzimati CONTROLOC Control: - ako ste alergični na pantoprazol ili bilo koji sastojak ovog lijeka (naveden u dijelu 6) - ako uzimate inhibitore HIV proteaze kao što su atazanavir i nelfinavir (za liječenje infekcije
Common Uncommon Rare 
Manje česte Rijetke
However, you may take CONTROLOC Control with antacids (e.g. magaldrate, alginic acid, sodium bicarbonate, aluminium hydroxide, magnesium carbonate, or combinations thereof), if needed. 
Ako je potrebno, CONTROLOC Control možete uzimati s antacidima (npr. megaldrat, alginatna kiselina, natrijev bikarbonat, aluminijev hidroksid, magnezijev karbonat ili kombinacije navedenih).
Production site Oranienburg Lehnitzstraße 70-98, 16515 Oranienburg Germany 
Lehnitzstrasse 70-98, 16515 Oranienburg
Especially medicines containing one of the following active substances: - HIV protease inhibitors such as atazanavir, nelfinavir (for the treatment of HIV-infection). 
Naročito lijekova koji sadrže sljedeće djelatne tvari: - inhibitore HIV proteaze, kao što su atazanavir i nelfinavir (za liječenje infekcije HIV-om).
CONTROLOC Control may reduce the absorption of active substances whose bioavailability is dependent on the gastric pH (e.g. ketoconazole). 
Control može smanjiti apsorpciju djelatnih tvari čija bioraspoloživost ovisi o pH želuca (npr. ketokonazol).
Pharmacotherapeutic group: Drugs for acid related disorders Proton pump inhibitors, ATC code: A02BC02 
Inhibitori protonske pumpe, ATK oznaka: A02BC02
What CONTROLOC Control looks like and contents of the pack The gastro-resistant tablets are yellow, oval, biconvex film-coated tablets imprinted with “P20” on one side. 
Control izgleda i sadržaj pakiranja Želučanootporne tablete su žute, ovalne, bikonveksne, filmom obložene tablete sa smeđom oznakom "P20" na jednoj strani.
You must not use CONTROLOC Control if you are taking HIV protease inhibitors. 
Control ako uzimate inhibitore HIV proteaze.
Liver enzymes increased (transaminas es, γ-GT) 
Poremećaji jetre i žuči povišenje jetrenih enzima (transaminaze , γ-GT)
- Very rare side effects (may affect up to 1 in 10,000 people): disorientation; reduction in the number of blood platelets, which may cause you to bleed or bruise more than normal; reduction in the number of white blood cells, which may lead to more frequent infections; coexisting abnormal reduction in the number of red and white blood cells, as well as platelets (seen in blood tests). 
- Vrlo rijetke nuspojave (mogu se javiti u do 1 na 10 000 osoba): dezorijentiranost; smanjenje broja krvnih pločica što može uzrokovati neuobičajena krvarenja i stvaranja modrica; smanjenje broja bijelih krvnih stanica što može dovesti do učestalih infekcija; istovremeno abnormalno smanjenje broja crvenih i bijelih krvnih stanica, te krvnih pločica (vidljivo na krvnim pretragama).
HIV-infection) See ‘Other medicines and CONTROLOC Control'. 
Pogledajte 'Ostali lijekovi i CONTROLOC Control'.
You may experience relief from your acid reflux and heartburn symptoms after just one day of treatment with CONTROLOC Control, but this medicine is not meant to bring immediate relief. 
Možete osjetiti olakšanje od simptoma refluksa kiseline ili žgaravice nakon samo jednog dana liječenja s CONTROLOC Control, ali ovaj lijek nije namijenjen trenutnom olakšanju simptoma.
Tell your doctor immediately, before or after taking this medicine, if you notice any of the following symptoms, which could be a sign of another, more serious, disease: - an unintentional loss of weight (not related to a diet or an exercise programme) - vomiting, particularly if repeated - vomiting blood; this may appear as dark coffee grounds in your vomit - you notice blood in your stools; which may be black or tarry in appearance - difficulty in swallowing or pain when swallowing - you look pale and feel weak (anaemia) - chest pain - stomach pain - severe and/or persistent diarrhoea, because this medicine has been associated with a small increase in infectious diarrhoea. 
Odmah obavijestite svog liječnika, prije ili nakon uzimanja ovog lijeka, ako primijetite neki od sljedećih simptoma koji može biti znak druge, ozbiljnije bolesti: - nenamjeran gubitak težine (koji nije vezan uz dijetu ili program tjelovježbe) - povraćanje, osobito ako se ponavlja - povraćanje krvi, što možete primijetiti u obliku tamnih zrnaca veličine zrna kave - krv u stolici, koja može biti crna ili poput katrana - teškoće pri gutanju ili bol pri gutanju - bljedoća ili osjećaj slabosti (anemija) - bol u prsnom košu - bol u trbuhu - težak i/ili stalan proljev, jer je ovaj lijek povezan sa malim porastom zaraznog proljeva - ako dobijete osip na koži, posebice na područjima izloženima suncu obavijestite svojeg liječnika što je prije moguće, jer ćete možda morati prekinuti liječenje lijekom CONTROLOC Control.
- methotrexate (used to treat rheumatoid arthritis, psoriasis, and cancer) - if you are taking methotrexate your doctor may temporarily stop your CONTROLOC Control treatment because pantoprazole can increase levels of methotrexate in the blood. 
- metotreksat (koristi se za liječenje reumatoidnog artritisa, psorijaze ili raka) - ako uzimate metotreksat liječnik će možda preporučiti da privremeno prekinete uzimati CONTROLOC
How to take CONTROLOC Control 
Kako uzimati CONTROLOC Control
- Printing ink: shellac, red, black and yellow iron oxide (E172) and ammonia solution, concentrated. 
- Tinta za označavanje: šelak, crveni, crni i žuti željezov oksid, (E172) i koncentrirana otopina amonijaka.
Decreased gastric acidity, due to any means - including proton pump inhibitors - increases gastric counts of bacteria normally present in the gastrointestinal tract. 
Gastrointestinalne infekcije izazvane bakterijama Smanjena kiselost u želucu koja nastaje iz bilo kojeg razloga-uključujući uzimanje inhibitora protonske pumpe-povećava brojnost bakterija koje su inače prisutne u gastrointestinalnom traktu.
Abdominal distension and bloating; Constipation ; Dry mouth; Abdominal pain and discomfort 
proljev; mučnina / povraćanje; distenzija abdomena i nadutost; konstipacija; suha usta; bol i nelagoda u abdomenu
Stop taking CONTROLOC Control when you are completely symptom-free. 
Control kada nastupi potpuno povlačenje simptoma.
Do not take CONTROLOC Control tablets for more than 4 weeks without consulting your doctor. 
Control tablete dulje od 4 tjedna bez savjetovanja s liječnikom.
- fracture of your hip, wrist or spine, especially if you already suffer from osteoporosis or if you are taking corticosteroids (which can increase the risk of osteoporosis). 
- smanjenje apsorpcije vitamina B12 i pomanjkanje vitamina B12 ako su vam tjelesne zalihe vitamina B12 već smanjene. - prijelom kuka, zapešća ili kralježnice, posebno ako već bolujete od osteoporoze ili ako uzimate kortikosteroide (koji mogu povećati rizik od osteoporoze).
CONTROLOC Control 20 mg gastro-resistant tablets Pantoprazole 
CONTROLOC Control 20 mg želučanootporne tablete pantoprazol
- Frequency not known: hallucination, confusion (especially in patients with a history of these symptoms); decreased level of sodium in blood; decreased level of magnesium in blood, rash, possibly with pain in the joints; feeling of tingling, prickling, pins and needles, burning sensation or numbness, inflammation in the large bowel, that causes persistent watery diarrhoea. 
Nepoznata učestalost: halucinacije, smetenost (pogotovo kod bolesnika koji su već imali te simptome), smanjenje razine natrija u krvi; smanjenje razine magnezija u krvi; osip, moguće praćen boli u zglobovima; osjećaj bockanja, peckanja, trnaca i mravinjanja, žarenja ili utrnulosti, upala debelog crijeva koja uzrokuje ustrajan vodenasti proljev.
Hepatocellular injury; Jaundice; Hepatocellular failure 
povišenje bilirubina oštećenje jetre; žutica; hepatocelular no zatajenje
CONTROLOC Control is indicated for short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults. 
Control je indiciran za kratkotrajno liječenje simptoma refluksa (npr. žgaravica, regurgitacija kiseline) u odraslih.
Agranulocytosis Thrombocytopenia ; Leukopenia, 
Poremećaji krvi i limfnog sustava agranulocitoza trombocitopenija; leukopenija, pancitopenija
- if you have been treated for heartburn or indigestion continuously for 4 or more weeks - if you are over 55 years old and taking non-prescription indigestion treatment on a daily basis - if you are over 55 years old with any new or recently changed reflux symptoms - if you have previously had a gastric ulcer or stomach surgery - if you have liver problems or jaundice (yellowing of skin or eyes) - if you regularly see your doctor for serious complaints or conditions - if you are due to have an endoscopy or a breath test called a C-urea test. - if you have ever had a skin reaction after treatment with a medicine similar to CONTROLOC 
- ako ste imali čir na želucu ili operaciju želuca - ako imate probleme s jetrom ili žuticu (žutilo kože ili očiju) - ako redovno posjećujete liječnika zbog neke ozbiljne bolesti ili stanja - ako ste naručeni na endoskopiju ili C-urea izdisajni test - ako ste ikad imali kožnu reakciju nakon terapije s lijekom sličnim lijeku CONTROLOC
How to store CONTROLOC Control 
Kako čuvati CONTROLOC Control
CONTROLOC Control is used for the short-term treatment of reflux symptoms (for example heartburn, acid regurgitation) in adults. 
Control se koristi za kratkotrajno liječenje simptoma refluksa (npr. žgaravica, vraćanje kiseline iz želuca u usta) u odraslih.
Pregnancy and, breast-feeding 
Trudnoća i dojenje
CONTROLOC Control 20 mg gastro-resistant tablets 
CONTROLOC Control 20 mg želučanootporne tablete
- Serious skin reactions (frequency not known: frequency cannot be estimated from the available data): rash with swelling, blistering or peeling of the skin, losing skin and bleeding around eyes, nose, mouth or genitals and rapid deterioration of your general health, or rash when exposed to the sun. - Other serious reactions (frequency not known): yellowing of the skin and eyes (due to severe liver damage), or kidney problems such as painful urination and lower back pain with fever. 
Tipični simptomi su: oticanje lica, usana, usta, jezika i/ili grla, što može uzrokovati teškoće pri gutanju ili disanju, koprivnjača (urtikarija), jaka omaglica s vrlo brzim otkucajima srca i izrazitim znojenjem. - ozbiljne kožne reakcije (nepoznata učestalost: učestalost se ne može procijeniti iz dostupnih podataka): osip sa oticanjem, stvaranje mjehurića na koži ili ljuštenje kože, gubljenje kože i krvarenje oko očiju, nosa, usta ili genitalija, brzo pogoršanje općeg zdravstvenog stanja, ili osip nastao kod izlaganja suncu. - ostale ozbiljne reakcije (nepoznata učestalost): žutilo kože i očiju (zbog teškog oštećenja jetre) ili problemi s bubrezima kao što je bolno mokrenje i bol u donjem dijelu leđa s vrućicom.
- warfarin and phenprocoumon (used to thin blood and prevent clots). 
Pogledajte 'Ne uzimajte CONTROLOC Control'. - ketokonazol (koristi se za gljivične infekcije) - varfarin i fenprokumon (koristi se za razrjeđivanje krvi i sprječavanje ugrušaka).
- if you are due to have a specific blood test (Chromogranin A) - if you are taking HIV protease inhibitors such as atazanavir; nelfinavir (for the treatment of 
Control koji smanjuje želučanu kiselinu - ako morate napraviti određenu krvnu pretragu (kromogranin A). - ako istodobno s pantoprazolom uzimate inhibitore HIV proteaze kao što su atazanavir i nelfinavir (za liječenje infekcije HIV-om), posavjetujte se s liječnikom.
Tabulated list of adverse reactions The following adverse reactions have been reported with pantoprazole. 
Prijavljene su sljedeće nuspojave pantoprazola.
If you forget to take CONTROLOC Control 
Prestanite uzimati CONTROLOC
Subacute cutaneous lupus erythematosus (see section 
Lyellov sindrom; erythema multiforme; fotoosjetljivo st; subakutni kožni lupus eritematodes (pogledajte dio 4.4.).
Hyperlipidaemias and lipid increases (triglycerides, cholesterol); 
Poremećaji metabolizma i prehrane hiperlipidemije i povišenja lipida (triglicerida, kolesterola); promjene u tjelesnoj težini hiponatrijemi ja; hipomagnezij emija; hipokalcijemi ja
EU (MA) number 
EU (MA) broj
1 After reconstitution, each dose (2 ml) contains 1.4-2.5 x 106 chondrogenic induced equine allogeneic peripheral blood-derived mesenchymal stem cells . 
1 Nakon miješanja, svaka doza (2 ml) sadrži hondrogeno inducirane, alogenične mezenhimske matične stanice izvedene iz periferne krvi konja (1,42,5 x 106).
1 vial of stem cell suspension + 1 vial of plasma suspension 
1 bočica sa suspenzijo m matičnih stanica + 1 bočica sa suspenzijo m plazme
Suspension (plasma): 1 ml 
Suspenzija (plazma): 1 ml
Suspension (plasma): vial (plastic). 
Suspenzija (plazma): bočica (plastična).
Horses Intraarticular use Suspension (stem cells): vial (plastic). 
Suspenzija (matične stanice): bočica (plastična).
No formal statistical comparisons were planned. 
Nisu planirane formalne statističke usporedbe.
Follow all the doctor's instructions carefully. 
Pažljivo slijedite sve liječničke upute.
Includes different bleeding events from different sites not listed individually c 
Uključuje različite događaje krvarenja iz različitih mjesta koji nisu pojedinačno navedeni c
Afinitor may also: weaken your immune system. 
Afinitor također može: oslabiti Vaš imunološki sustav.
What Afinitor is and what it is used for 
Što je Afinitor i za što se koristi
Open the blister just before taking the tablets. 
Blister otvorite neposredno prije uzimanja tableta.
Plus exemestane b 
Plus eksemestan b
Population n 
Populacija n
Intermediate risk 
Srednji rizik
NSE: Neuron specific enolase 
NSE: Neuron specifična enolaza
Your doctor will tell you how many tablets of Afinitor to take. 
Liječnik će Vam reći koliko tableta Afinitora ćete uzimati.
CgA: Chromogranin A 
CgA: Kromogranin A
If you take more Afinitor than you should 
Ako uzmete više Afinitora nego što ste trebali
Discontinue treatment if failure to recover within 4 weeks. 
Prekinuti liječenje ako nema oporavka unutar 4 tjedna.
They may differ from the general information contained in this leaflet. 
One se mogu razlikovati od općih informacija koje sadrži ova uputa.
Frequency based upon number of women from 10 to 55 years of age in the pooled data 
Učestalost temeljena na broju žena od 10 do 55 godina u objedinjenim podacima
Probability (%) 
Vjerojatnost (%)
Afinitor could harm your unborn baby and is not recommended during pregnancy. 
Afinitor može naštetiti Vašem nerođenom djetetu te se ne preporučuje tijekom trudnoće.
Your doctor will discuss with you whether you should take this medicine during your pregnancy. 
Vaš će liječnik s Vama raspraviti hoćete li uzimati ovaj lijek tijekom trudnoće.
Children and adolescents Afinitor is not to be used in children or adolescents (age below 18 years). 
Djeca i adolescenti Afinitor nije namijenjen za primjenu u djece ili adolescenata (mlađi od 18 godina).
STOP taking Afinitor and seek medical help immediately if you experience any of the following signs of an allergic reaction: 
PRESTANITE uzimati Afinitor i odmah potražite liječničku pomoć ako osjetite bilo koji od sljedećih znakova alergijske rekacije:
Other medicines and Afinitor 
Drugi lijekovi i Afinitor
The increase in exemestane levels is unlikely to have an impact on efficacy or safety. 
Nije vjerojatno da bi porast razina eksemestana imao učinka na djelotvornost ili sigurnost primjene.
Reactivation of infection is an expected event during periods of immunosuppression. 
Reaktivacija infekcije je očekivani događaj tijekom razdoblja imunosupresije.
The safety and efficacy of Afinitor in children aged 0 to 18 years have not been established. 
Sigurnost i djelotvornost Afinitora u djece u dobi od 0 do 18 godina nisu još ustanovljene.
Some mouthwashes and gels can make ulcers worse, so do not try anything without checking with your doctor first. 
Neke otopine za ispiranje usta i gelovi mogu pogoršati ranice, stoga ne pokušavajte ništa bez prethodne provjere s Vašim liječnikom.
Stratified log-rank test 
Stratificirano log-rank testom
What you need to know before you take Afinitor 
Što morate znati prije nego počnete uzimati Afinitor
Re-initiate treatment at same dose. 
Ponovno započeti liječenje u istoj dozi.
Independent radiological review 
Neovisna radiološka procjena
Talk to your doctor before taking Afinitor: if you have any problems with your liver or if you have ever had any disease which may have affected your liver. 
Obratite se svom liječniku prije nego uzmete Afinitor: ako imate bilo kakvih problema s jetrom ili ako ste ikada imali neku bolest kojom je mogla biti zahvaćena jetra.